No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ALPN240517C60000
- 6.50
- +1.50+30.00%
15min DelayClose May 17 15:56 ET
6.50High6.50Low
6.50Open5.00Pre Close1 Volume21 Open Interest60.00Strike Price650.00Turnover1573.05%IV1.89%PremiumMay 17, 2024Expiry Date4.97Intrinsic Value100Multiplier-1DDays to Expiry1.53Time Value100Contract SizeAmericanOptions Type0.7584Delta0.0385Gamma10.48Leverage Ratio-56.0000Theta0.0000Rho7.95Eff Leverage0.0016Vega
Intraday
- 5D
- 1D
News
Express News | Wedbush Reiterates Neutral on Alpine Immune Sciences, Maintains $65 Price Target
Analysts Offer Insights on Healthcare Companies: Eyenovia (EYEN), Alpine Immune Sciences (ALPN) and GoodRx Holdings (GDRX)
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone
Alpine Immune Sciences (ALPN) and Vertex Pharmaceuticals (VRTX) said Friday the waiting period under the Hart-Scott-Rodino antitrust act related to their merger deal expired Thursday. Vertex has agree
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
On May 9, 2024, Alpine Immune Sciences Inc (NASDAQ:ALPN), a prominent player in the field of immunotherapy for autoimmune and inflammatory diseases, disclosed its financial outcomes for the first quarter ending March 31, 2024.
RBC Capital Sticks to Its Hold Rating for Alpine Immune Sciences (ALPN)
Alpine Immune | 10-Q: Quarterly report
Comments
Keep an eye on these M&As: 👀
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt(ADTX.US$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
$Century Therapeutics(IPSC.US$ to acquire Clade Tx
$Eliem Therapeutics(ELYM.US$ to acquire Tenet Med.
$Incyte(INCY.US$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals(DCPH.US$
...
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt(ADTX.US$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
$Century Therapeutics(IPSC.US$ to acquire Clade Tx
$Eliem Therapeutics(ELYM.US$ to acquire Tenet Med.
$Incyte(INCY.US$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals(DCPH.US$
...
7
No megadeals in biotech so far this yr, but on track for record amount >$1 bil deals,
2 biggest deals this yr:
$Vertex Pharmaceuticals(VRTX.US$ paid $4.9 bil for $Alpine Immune(ALPN.US$
$Gilead Sciences(GILD.US$ paid $4.3 bil for $CBAY
Bolt-on deals likely to continue to be the dominant story in 2024, which means we could also see more of this trend...
Last yr 84% of M&A deal dollars were for Biotechs w/ Phase 3 & Marketed assets,
In the first four months of 2024 56% of M&A deal dollar went towards P...
2 biggest deals this yr:
$Vertex Pharmaceuticals(VRTX.US$ paid $4.9 bil for $Alpine Immune(ALPN.US$
$Gilead Sciences(GILD.US$ paid $4.3 bil for $CBAY
Bolt-on deals likely to continue to be the dominant story in 2024, which means we could also see more of this trend...
Last yr 84% of M&A deal dollars were for Biotechs w/ Phase 3 & Marketed assets,
In the first four months of 2024 56% of M&A deal dollar went towards P...
6
$Alpine Immune(ALPN.US$
🤩🤩🤩 SELL ALL IN APRIL AND TRAVEL (+ 💰💰💰💰💰) THEN SELL ALL AGAIN IN MAY (- $$$$$$ ) AND RUN AWAY 😭😭😭
47. G = Make Money From Thin Air, Block Short, Keep Repeating (Pump and Drop) to trap Buyers or Create Fake Symbols to Rob Money From Investors
47. T = Track and Kill by Weapons, Dark Magics, Nightmare, Accident, Sickness, Burn, Drown....them, and kill their children too, if they teach their children the same
🤩🤩🤩 SELL ALL IN APRIL AND TRAVEL (+ 💰💰💰💰💰) THEN SELL ALL AGAIN IN MAY (- $$$$$$ ) AND RUN AWAY 😭😭😭
47. G = Make Money From Thin Air, Block Short, Keep Repeating (Pump and Drop) to trap Buyers or Create Fake Symbols to Rob Money From Investors
47. T = Track and Kill by Weapons, Dark Magics, Nightmare, Accident, Sickness, Burn, Drown....them, and kill their children too, if they teach their children the same
$ProKidney(PROK.US$ sank more than 15% Thursday as the biotech snapped a five-session winning streak that saw its price rise some 130% in just days.
PROK fell 15.5% to close at $2.40, ending a run-up that began last Thursday, April 11, despite no apparent news.
Shares gained 132.4% between the stock's $1.45 close on April 10 and its $3.37 peak this past Wednesday.
ProKidney, which is trying t...
PROK fell 15.5% to close at $2.40, ending a run-up that began last Thursday, April 11, despite no apparent news.
Shares gained 132.4% between the stock's $1.45 close on April 10 and its $3.37 peak this past Wednesday.
ProKidney, which is trying t...
7
$ProKidney(PROK.US$ rose more than 30% Tuesday as the biotech firm rallied for the fourth straight session – a run-up that's seen the stock rise nearly 90% in less than a week.
PROK gained 30.1% to close at $2.72, up 87.6% from last Wednesday's close at $1.45.
ProKidney has been soaring despite no news announcements, although the stock's rally began the day after $Vertex Pharmaceuticals(VRTX.US$ unveiled plans to buy biotech $Alpine Immune(ALPN.US$ for $4.9 ...
PROK gained 30.1% to close at $2.72, up 87.6% from last Wednesday's close at $1.45.
ProKidney has been soaring despite no news announcements, although the stock's rally began the day after $Vertex Pharmaceuticals(VRTX.US$ unveiled plans to buy biotech $Alpine Immune(ALPN.US$ for $4.9 ...
4
Read more